About: Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 02 February 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в лютому 2009 (uk) scientific article published on 02 February 2009 (en) مقالة علمية نشرت في 02 فبراير 2009 (ar)
publication date	wds:Q37144843-A42CD130-99B6-47BD-9BC2-D10BA9948CED
publication date	2009-02-02 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37144843-A9E61E95-3101-4CE9-A203-DCBF4B8A9B1F
language of work or name	English
cites work	wds:Q37144843-068A95D5-F0B1-4463-9D61-0BD81C9A6119 wds:Q37144843-14E01E78-9AEE-497F-B5AA-C29B87B181B0 wds:Q37144843-50790A30-58B7-42DC-BB95-D4E762ECCC76 wds:Q37144843-52779354-C1C7-4C22-A265-926FFA61ADAD wds:Q37144843-68AE9345-18D6-48ED-87D5-02AF5FB02542 wds:Q37144843-6B542312-FCD8-4F9C-8362-286F06A0FCD1 wds:Q37144843-73AD5528-2E48-4E4A-8FEA-4394C93B444D wds:Q37144843-88F9C531-70AE-4AC4-BE03-95B9C671C2A7 wds:Q37144843-991E1182-8493-4D35-AF44-009D3C385F53 wds:Q37144843-A0FC7333-87C9-4F0A-B834-C6A5B797992E wds:Q37144843-A7032939-E047-4CF8-9126-FF34173EA78F wds:Q37144843-B14AA4E9-FFC6-4FDD-A270-8EE3FCA291D2 wds:Q37144843-BC4D2B4D-8472-44E1-8E36-99C53BB18D0B wds:Q37144843-C9C75A67-1242-40A8-B8D6-CCA74D27E91B wds:Q37144843-EAC9A823-174F-4D39-B13C-E9797B3D3DFF wds:Q37144843-EDDD728B-6CAB-4377-891D-92608AB37603 wds:Q37144843-EF48D08D-78C0-4E35-898E-B2FCCEEB0B5F wds:Q37144843-F79C8AB3-5849-4B19-9CFE-D9637FD32B09
cites work	Pharmacokinetics of ciprofloxacin XR (1000 mg) versus levofloxacin (500 mg) in plasma and urine of male and female healthy volunteers receiving a single oral dose What have we learned from pharmacokinetic and pharmacodynamic theories? Antimicrobial activity of doripenem (S-4661): a global surveillance report (2003). Doripenem Activities of doripenem (S-4661) against drug-resistant clinical pathogens Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing Bacterial biofilms and catheters in experimental urinary tract infection Use of pharmacokinetic-pharmacodynamic target attainment analyses to support phase 2 and 3 dosing strategies for doripenem In vivo pharmacodynamic profiling of doripenem against Pseudomonas aeruginosa by simulating human exposures The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter A double-blind, randomized comparison of levofloxacin 750 mg once-daily for five days with ciprofloxacin 400/500 mg twice-daily for 10 days for the treatment of complicated urinary tract infections and acute pyelonephritis Epidemiology of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli In vitro and in vivo antibacterial activities of S-4661, a new carbapenem. Comparative in vitro antimicrobial activity of a new carbapenem, doripenem: tentative disc diffusion criteria and quality control Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms Spectrum and antibiotic resistance of uropathogens from hospitalised patients with urinary tract infections: 1994-2005. Urinary excretion and bactericidal activities of a single oral dose of 400 milligrams of fleroxacin versus a single oral dose of 800 milligrams of pefloxacin in healthy volunteers Urinary excretion and bactericidal activities of gemifloxacin and ofloxacin after a single oral dose in healthy volunteers
author name string	wds:Q37144843-241C3E61-96EF-4A4B-88F5-FCC4620B4485 wds:Q37144843-3D17A5B1-2C26-4D28-8E84-A3ACF831B564 wds:Q37144843-40687064-6718-43EC-A733-6987EBB88214 wds:Q37144843-84C27C66-8735-47D6-B186-BEF8955C42A0 wds:Q37144843-F913948D-7657-4FB4-B7F0-B2F2051E8FBE
author name string	Kurt G Naber Wolfgang Weidner Rebecca Redman Florian M E Wagenlehner Christine Wagenlehner
rdfs:label	Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (en) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (nl) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (ast)
skos:prefLabel	Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (en) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (nl) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (ast)
name	Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (en) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (nl) Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (ast)
title	wds:Q37144843-8EA67316-A4C2-4998-B5F4-34AE4DCE3BD7
title	Urinary bactericidal activity of Doripenem versus that of levofloxacin in patients with complicated urinary tract infections or pyelonephritis (en)
page(s)	wds:Q37144843-04C46647-6FDB-41E8-88E9-EE8D59AA18E9
page(s)	1567-1573
instance of	wds:Q37144843-D0B78713-3E7D-4820-AA10-277C92D4C5A5
instance of	scholarly article
main subject	wds:Q37144843-28BADE1D-66D2-49E4-9192-3171FBD0EBBA wds:Q37144843-B9EAF538-A299-4875-80C0-C052D3444989
main subject	urinary tract infection levofloxacin
PubMed ID	wds:Q37144843-15445BD6-4243-4BEC-91AA-37E63D58C01D
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/19188391
PubMed ID	19188391
published in	wds:Q37144843-3F929509-DEA5-4888-9148-845B84E72EB3
published in	Antimicrobial Agents and Chemotherapy
issue	wds:Q37144843-A7A5E380-A937-48E9-8649-5BC67CB6ACA8
volume	wds:Q37144843-B9039637-4DCF-4631-9172-3165EBED7742
issue	4
volume	53
DOI	wds:Q37144843-5D795252-EB58-4C68-8164-3E47A51990A6
DOI	http://dx.doi.org/10.1128/AAC.01133-08
DOI	10.1128/AAC.01133-08
PMCID	wds:Q37144843-D4B08541-E2DC-4226-9E4E-051D2D5835D4
PMCID	2663091

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 172 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software